Blood Pressure and Cardiac Autonomic Adaptations to Isometric Exercise Training

August 31, 2021 updated by: Canterbury Christ Church University

Blood Pressure and Cardiac Autonomic Adaptations to Isometric Exercise Training: a Randomised Sham-controlled Study

A randomized, sham-controlled intervention measuring the effects of isometric exercise training (IET) on blood pressure and cardiac autonomics.

IET has been proven effective in a plethora of randomized trials, but very little research has employed a sham-controlled design. This researched involved the recruitment of 30 participants who completed a 4 week IET intervention, sham control of the IET intervention, or a non-intervention control period. Pre and post blood pressure and cardiac autonomic measures were acquired and analysed.

The hypothesis of this trial was a significant effect of IET on blood pressure, with no such effects following the sham control or normal control interventions.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kent
      • Canterbury, Kent, United Kingdom
        • Canterbury Christ Church University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Healthy with no significant health conditions contraindicating exercise
  • Over 18 years of age
  • Physically inactive

Exclusion Criteria:

  • Achieving current physical activity guidelines
  • Abnormal resting ECG
  • under 18

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: IET
Participants allocated to this arm performed 4 weeks of isometric wall squat exercise training, 3 times per week.
A form of exercise involving static contraction against a wall, sustained for 2 minutes x4 sets per session. 3 sessions a week were required. The intensity was designed to achieve 95% of the participants maximum heart rate.
SHAM_COMPARATOR: Sham
Participants allocated to this arm performed 4 weeks of isometric wall squat training, but the training prescription was intentionally provided at an insufficient intensity to achieve any physiology stimulus.
A form of exercise involving static contraction against a wall, sustained for 2 minutes x4 sets per session. 3 sessions a week were required. The intensity was designed to achieve 95% of the participants maximum heart rate.
NO_INTERVENTION: No intervention control
Participants allocated to this arm did not perform any exercise and were required to maintain usual daily habits.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood pressure (systolic, diastolic and mean BP)
Time Frame: At the start of the intervention (pre 4 week intervention)
Resting office blood pressure measured at brachial artery
At the start of the intervention (pre 4 week intervention)
Blood pressure (systolic, diastolic and mean BP)
Time Frame: At the end of the intervention (post 4 weeks)
Resting office blood pressure measured at brachial artery
At the end of the intervention (post 4 weeks)
Cardiac autonomics measured at HRV
Time Frame: At the start of the intervention (pre 4 week intervention)
LF and HF power spectral measures
At the start of the intervention (pre 4 week intervention)
Cardiac autonomics measured at HRV
Time Frame: At the end of the intervention (post 4 weeks)
LF and HF power spectral measures
At the end of the intervention (post 4 weeks)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
continuous 5-minute blood pressure (systolic, diastolic and mean BP)
Time Frame: At the start of the intervention (pre 4 week intervention)
5 minute mean of resting blood pressure measured beat-to-beat
At the start of the intervention (pre 4 week intervention)
continuous 5-minute blood pressure (systolic, diastolic and mean BP)
Time Frame: At the end of the intervention (post 4 weeks)
5 minute mean of resting blood pressure measured beat-to-beat
At the end of the intervention (post 4 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 15, 2019

Primary Completion (ACTUAL)

December 29, 2019

Study Completion (ACTUAL)

September 11, 2020

Study Registration Dates

First Submitted

August 16, 2021

First Submitted That Met QC Criteria

August 23, 2021

First Posted (ACTUAL)

August 27, 2021

Study Record Updates

Last Update Posted (ACTUAL)

September 5, 2021

Last Update Submitted That Met QC Criteria

August 31, 2021

Last Verified

August 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 18/SAS/47C

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension

Clinical Trials on Isometric exercise training

Subscribe